3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator

This publication has 23 references indexed in Scilit:

• Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation
  Biochemical Pharmacology, 1995
• Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
  Journal of Clinical Investigation, 1995
• Mechanisms of toxicity of 3′-azido-3′- deoxythymidine: Its interaction with adenylate kinase
  Biochemical Pharmacology, 1994
• AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic Function
  Biochemical and Biophysical Research Communications, 1993
• The friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication
  Biochemical Pharmacology, 1992
• The 5′-triphosphates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxynucleosides inhibit DNA polymerase γ by different mechanisms
  Biochemical and Biophysical Research Communications, 1991
• Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
  The Lancet, 1991
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990
• Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-dhoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication
  Biochemical Pharmacology, 1989
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987